US Stock MarketDetailed Quotes

CMND Clearmind Medicine

Watchlist

1.2350
+0.0450+3.78%

Trading Dec 20 11:11 ET

5.41MMarket Cap-0.58P/E (TTM)

Clearmind Medicine Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Jul 31, 2024

(Q2)Apr 30, 2024

(Q1)Jan 31, 2024

(FY)Oct 31, 2023

(Q4)Oct 31, 2023

(Q3)Jul 31, 2023

(Q2)Apr 30, 2023

(Q1)Jan 31, 2023

(FY)Oct 31, 2022

(Q4)Oct 31, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

33.40%1.47M

-21.29%1.3M

-24.50%1.38M

-0.77%4.56M

-105.15%-33.99K

5.83%1.1M

-3.49%1.66M

12.22%1.83M

111.36%4.59M

-38.61%660.13K

Selling and administrative expenses

34.14%1.13M

-26.74%980.55K

-7.14%1.16M

49.79%3.41M

96.85%-8.42K

6.04%838.93K

63.42%1.34M

-4.27%1.25M

27.37%2.28M

-136.30%-267.67K

-General and administrative expense

34.14%1.13M

-26.74%980.55K

-7.14%1.16M

49.79%3.41M

96.85%-8.42K

6.04%838.93K

63.42%1.34M

-4.27%1.25M

27.37%2.28M

-136.30%-267.67K

Research and development costs

31.04%345.88K

1.70%322.96K

-61.29%227.48K

-50.68%1.12M

-105.99%-52.54K

5.17%263.95K

-64.59%317.57K

76.75%587.63K

492.34%2.26M

160.97%877.66K

Depreciation amortization depletion

----

-46.21%26.97K

----

3,194.70%50.14K

----

-Depreciation and amortization

----

-46.21%26.97K

----

3,194.70%50.14K

----

Operating profit

-33.40%-1.47M

21.29%-1.3M

24.50%-1.38M

0.77%-4.56M

105.15%33.99K

-5.83%-1.1M

3.49%-1.66M

-12.22%-1.83M

-111.36%-4.59M

38.61%-660.13K

Net non-operating interest income expense

391.27%85.02K

469.14%33.96K

236.25%60.58K

503.91%42.79K

114.16%1.5K

301.62%17.31K

5.97K

18.02K

-10.59K

Non-operating interest income

391.27%85.02K

469.14%33.96K

236.25%60.58K

----

--17.31K

--5.97K

--18.02K

----

Total other finance cost

----

-503.91%-42.79K

----

--10.59K

----

Other net income (expense)

-232.03%-665.1K

195.45%398.09K

293.87%157.12K

-287.48%-1.71M

-552.93%-1.71M

639.62%503.75K

-413.31%-417.06K

-1,499.93%-81.04K

-1,610.85%-440.26K

-262.14K

Gain on sale of security

-228.75%-648.61K

195.45%398.09K

293.87%157.12K

-287.48%-1.71M

-552.93%-1.71M

639.62%503.75K

-413.31%-417.06K

-1,499.93%-81.04K

-2,121.17%-440.26K

---262.14K

Special income (charges)

----

--0

----

--0

----

-Less:Impairment of capital assets

----

--0

----

--0

----

Other non- operating income (expenses)

---16.5K

----

Income before tax

-252.57%-2.05M

57.84%-871.46K

38.49%-1.17M

-23.33%-6.22M

-79.67%-1.68M

49.14%-581.82K

-15.02%-2.07M

-15.72%-1.9M

-129.39%-5.04M

15.27%-932.86K

Income tax

742.29%42.59K

296.63%36.76K

5,856.25%201.5K

-42.75%12.56K

-70.18%6.54K

-6.63K

9.27K

3.38K

21.94K

Net income

-264.04%-2.09M

56.26%-908.22K

27.99%-1.37M

-23.04%-6.23M

-76.23%-1.68M

49.72%-575.19K

-15.53%-2.08M

-15.93%-1.9M

-130.38%-5.07M

13.28%-954.8K

Net income continuous Operations

-264.04%-2.09M

56.26%-908.22K

27.99%-1.37M

-23.04%-6.23M

-76.23%-1.68M

49.72%-575.19K

-15.53%-2.08M

-15.93%-1.9M

-130.38%-5.07M

13.28%-954.8K

Minority interest income

Net income attributable to the parent company

-264.04%-2.09M

56.26%-908.22K

27.99%-1.37M

-23.04%-6.23M

-76.23%-1.68M

49.72%-575.19K

-15.53%-2.08M

-15.93%-1.9M

-130.38%-5.07M

13.28%-954.8K

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-264.04%-2.09M

56.26%-908.22K

27.99%-1.37M

-23.04%-6.23M

-76.23%-1.68M

49.72%-575.19K

-15.53%-2.08M

-15.93%-1.9M

-130.38%-5.07M

13.28%-954.8K

Basic earnings per share

75.72%-0.59

98.32%-0.28

96.37%-0.9

73.66%-30.7892

86.57%-2.7705

90.63%-2.43

59.72%-16.62

36.83%-24.8

-64.35%-116.9127

25.93%-20.6357

Diluted earnings per share

75.72%-0.59

98.32%-0.28

96.37%-0.9

73.66%-30.7892

86.57%-2.7705

90.63%-2.43

59.72%-16.62

36.83%-24.8

-64.35%-116.9127

25.93%-20.6357

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Jul 31, 2024	(Q2)Apr 30, 2024	(Q1)Jan 31, 2024	(FY)Oct 31, 2023	(Q4)Oct 31, 2023	(Q3)Jul 31, 2023	(Q2)Apr 30, 2023	(Q1)Jan 31, 2023	(FY)Oct 31, 2022	(Q4)Oct 31, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	33.40%1.47M	-21.29%1.3M	-24.50%1.38M	-0.77%4.56M	-105.15%-33.99K	5.83%1.1M	-3.49%1.66M	12.22%1.83M	111.36%4.59M	-38.61%660.13K
Selling and administrative expenses	34.14%1.13M	-26.74%980.55K	-7.14%1.16M	49.79%3.41M	96.85%-8.42K	6.04%838.93K	63.42%1.34M	-4.27%1.25M	27.37%2.28M	-136.30%-267.67K
-General and administrative expense	34.14%1.13M	-26.74%980.55K	-7.14%1.16M	49.79%3.41M	96.85%-8.42K	6.04%838.93K	63.42%1.34M	-4.27%1.25M	27.37%2.28M	-136.30%-267.67K
Research and development costs	31.04%345.88K	1.70%322.96K	-61.29%227.48K	-50.68%1.12M	-105.99%-52.54K	5.17%263.95K	-64.59%317.57K	76.75%587.63K	492.34%2.26M	160.97%877.66K
Depreciation amortization depletion	----	----	----	-46.21%26.97K	----	----	----	----	3,194.70%50.14K	----
-Depreciation and amortization	----	----	----	-46.21%26.97K	----	----	----	----	3,194.70%50.14K	----
Operating profit	-33.40%-1.47M	21.29%-1.3M	24.50%-1.38M	0.77%-4.56M	105.15%33.99K	-5.83%-1.1M	3.49%-1.66M	-12.22%-1.83M	-111.36%-4.59M	38.61%-660.13K
Net non-operating interest income expense	391.27%85.02K	469.14%33.96K	236.25%60.58K	503.91%42.79K	114.16%1.5K	301.62%17.31K	5.97K	18.02K	-10.59K	-10.59K
Non-operating interest income	391.27%85.02K	469.14%33.96K	236.25%60.58K	----	----	--17.31K	--5.97K	--18.02K	----	----
Total other finance cost	----	----	----	-503.91%-42.79K	----	----	----	----	--10.59K	----
Other net income (expense)	-232.03%-665.1K	195.45%398.09K	293.87%157.12K	-287.48%-1.71M	-552.93%-1.71M	639.62%503.75K	-413.31%-417.06K	-1,499.93%-81.04K	-1,610.85%-440.26K	-262.14K
Gain on sale of security	-228.75%-648.61K	195.45%398.09K	293.87%157.12K	-287.48%-1.71M	-552.93%-1.71M	639.62%503.75K	-413.31%-417.06K	-1,499.93%-81.04K	-2,121.17%-440.26K	---262.14K
Special income (charges)	----	----	----	--0	----	----	----	----	--0	----
-Less:Impairment of capital assets	----	----	----	--0	----	----	----	----	--0	----
Other non- operating income (expenses)	---16.5K	----	----	----	----	----	----	----	----	----
Income before tax	-252.57%-2.05M	57.84%-871.46K	38.49%-1.17M	-23.33%-6.22M	-79.67%-1.68M	49.14%-581.82K	-15.02%-2.07M	-15.72%-1.9M	-129.39%-5.04M	15.27%-932.86K
Income tax	742.29%42.59K	296.63%36.76K	5,856.25%201.5K	-42.75%12.56K	-70.18%6.54K	-6.63K	9.27K	3.38K	21.94K	21.94K
Net income	-264.04%-2.09M	56.26%-908.22K	27.99%-1.37M	-23.04%-6.23M	-76.23%-1.68M	49.72%-575.19K	-15.53%-2.08M	-15.93%-1.9M	-130.38%-5.07M	13.28%-954.8K
Net income continuous Operations	-264.04%-2.09M	56.26%-908.22K	27.99%-1.37M	-23.04%-6.23M	-76.23%-1.68M	49.72%-575.19K	-15.53%-2.08M	-15.93%-1.9M	-130.38%-5.07M	13.28%-954.8K
Minority interest income
Net income attributable to the parent company	-264.04%-2.09M	56.26%-908.22K	27.99%-1.37M	-23.04%-6.23M	-76.23%-1.68M	49.72%-575.19K	-15.53%-2.08M	-15.93%-1.9M	-130.38%-5.07M	13.28%-954.8K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-264.04%-2.09M	56.26%-908.22K	27.99%-1.37M	-23.04%-6.23M	-76.23%-1.68M	49.72%-575.19K	-15.53%-2.08M	-15.93%-1.9M	-130.38%-5.07M	13.28%-954.8K
Basic earnings per share	75.72%-0.59	98.32%-0.28	96.37%-0.9	73.66%-30.7892	86.57%-2.7705	90.63%-2.43	59.72%-16.62	36.83%-24.8	-64.35%-116.9127	25.93%-20.6357
Diluted earnings per share	75.72%-0.59	98.32%-0.28	96.37%-0.9	73.66%-30.7892	86.57%-2.7705	90.63%-2.43	59.72%-16.62	36.83%-24.8	-64.35%-116.9127	25.93%-20.6357
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Heat List

Overall

No Data